CARE & COACH Akademie
CARE & COACH Akademie is a Köln-based digital continuing-education provider that delivers oncology-nursing certifications, paid modules, webinars, and short videos to nursing professionals in the German-speaking market, with revenue from course fees and pharmaceutical sponsorships.
- Company typePrivate
- Founded2022
- HeadquartersKöln, Germany
- Headcount—
- GTM typeB2C
- OfferingServices
What CARE & COACH Akademie does
CARE & COACH Akademie GmbH is a Köln-based digital continuing-education provider focused on oncology nursing professionals in the German-speaking market. Its core offering is a hybrid learning platform that combines paid modular courses — including the six-month OncoCoach certification and indication-specific programs such as TYPER-Coach (HR+/HER2- breast cancer) — with free content formats such as webinars and the short-form 'Clips' video series. The curriculum is mapped to recognized German continuing-education accreditation frameworks for nursing, positioning the company within a regulated professional-development niche rather than the broader consumer e-learning market.
The platform architecture is content-centric: structured modules priced at approximately €50–70 are layered with sponsored webinars and short videos, and the company operates paid acquisition channels (LinkedIn Ads, Google Ads) to reach its professional audience. Distribution is being extended geographically through new in-person OncoCoach cohorts planned for Kassel, Lübeck, and Ludwigsburg in spring 2027, on top of the Köln base.
The business model is a hybrid of B2C course fees (individual nurses and practitioners paying per module) and B2B sponsorship from a network of more than 20 pharmaceutical partners organized into Gold and Basis sponsorship tiers that underwrite free educational content. The organization is structured as a private German GmbH with a small team of approximately 5–7 employees, and there are no publicly disclosed funding rounds or audited revenue figures.
CARE & COACH Akademie firmographics
Firmographics- Name
- CARE & COACH Akademie
- Legal name
- CARE & COACH Akademie GmbH
- Website
- https://care-and-coach.de
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Short description
- CARE & COACH Akademie is a Köln-based digital continuing-education provider that delivers oncology-nursing certifications, paid modules, webinars, and short videos to nursing professionals in the German-speaking market, with revenue from course fees and pharmaceutical sponsorships.
- Ownership category
- akta.pro rank
CARE & COACH Akademie industry classification
Industry- Product category
- Continuing Medical Education
- NAICS
- Professional and Management Development Training (611430)
- SIC
- Services-Educational Services (8200)
- akta.pro primary industry
- Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)
- akta.pro secondary industry
- Medical Oncology (HLAKAFAB)
Keywords
Where CARE & COACH Akademie is headquartered
LocationHeadquarters
- HQ city
- Köln
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
CARE & COACH Akademie business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Technology or R&D, Operations
Revenue model
- Course and Module Fees: Individual OncoCoach modules are sold at €50-70 per module. The comprehensive OncoCoach program combines workshops, webinars, and e-learnings for a holistic training experience. Certificates and continuing education points (Fortbildungspunkte) are provided upon completion.
- Free Educational Content: Free webinars and Clips video series serve as lead generation and community building, with pharmaceutical company sponsorships supporting this content
- Pharmaceutical Sponsorships: Gold and Basis Sponsoring arrangements with pharmaceutical companies in oncology, hematology, and supportive care. Companies sponsor specific courses and content in exchange for brand presence and healthcare professional engagement.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Individual OncoCoach modules (e.g., CAR-T cell therapy, biomarker-adapted therapy, antiemetics) |
| Freemium | Pay-as-you-go | Live and On-Demand Webinars |
| Freemium | Pay-as-you-go | Clips Video Series |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
CARE & COACH Akademie product offering
Product offeringCore offering
CARE & COACH Akademie operates a digital continuing education platform for oncology nursing professionals in German-speaking regions, delivering hybrid training that combines in-person workshops, live webinars, and asynchronous e-learning modules. The flagship OncoCoach six-month certification program covers diagnostics, oncology therapies, patient coaching, and communication skills, while individual modules (e.g., CAR-T cell therapy, biomarker-adapted therapy, antiemetics) are sold at €50–70 each alongside free webinars and short-form video clips.
Product overview
CARE & COACH Akademie is a digital continuing education platform for nursing professionals in oncology. The platform operates as a multi-product ecosystem consisting of four core offerings: OncoCoach (a comprehensive six-month hybrid certification program), Webinare (live and on-demand pharmaceutical training webinars), Clips (short-form video series), and TYPER-Coach (a study-specific training program). The OncoCoach program serves as the flagship product, combining in-person workshops with E-learning modules and live webinars. Individual add-on modules covering specific oncology topics (CAR-T therapy, biomarker therapy, antiemetics, etc.) can be purchased separately at 50-70 euros each. The Clips product delivers expert-presented educational content in compact 3-minute episodes organized into seasons. Webinars cover pharmaceutical topics like drug mechanisms, administration, and side effects with certificates and continuing education credits. All offerings emphasize practical application for clinical and practice settings, with the platform's mission centered on professionalizing the nursing profession through innovative training.
Differentiator
Problem solved
Functional benefit
Brands
- OncoCoach: Hybrid training course for oncology nurses to become certified OncoCoaches, covering diagnostics, therapies, patient coaching, and communication skills
- TYPER-Coach
- Webinare
- Clips
Products and services
- OncoCoach Certification Program A six-month hybrid certification program for oncology nursing professionals that combines in-person workshops, live webinars, and e-learning modules to train nurses in diagnostics, oncology therapies (subcutaneous, oral, multimodal), patient and family coaching, and communication skills for clinical and practice settings.
- Webinare (Drug-Relevant Training Webinars) Live and on-demand pharmaceutical training webinars covering drug mechanisms, administration, side effects, and patient management topics in oncology (e.g., NSCLC therapy, CINV, immunotherapy safety, antibody-drug conjugates). Approximately two-hour sessions, free, with certificates and Fortbildungspunkte (continuing education points) upon completion.
- Clips Video Series Short-form video content organized in seasons and episodes of approximately three minutes each, currently featuring myeloproliferative neoplasms with five seasons of five episodes each. Expert-presented, professionally produced educational video clips for nursing professionals.
- TYPER-Coach Training program for staff at TYPER study centers covering typology-based coaching for therapy adherence in HR+/HER2- breast cancer patients. Part 1 consists of e-learning modules; Part 2 is an in-person or online workshop on coaching techniques for therapy adherence.
- OncoCoach Individual Modules Individually purchasable topical modules within the OncoCoach curriculum, including CAR-T cell therapy (€70), biomarker-adapted therapy (€70), antiemetics (€70), breast cancer adjuvant therapy (€70), return-to-work management (€70), and an Immunonkologie introduction (€50).
Quantifiable outcome
- Over 20 topics covered in the OncoCoach curriculum
- +2 more outcomes
Companies that use CARE & COACH Akademie
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
CARE & COACH Akademie technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
Feature3 records
CARE & COACH Akademie partnerships and signals
Strategic signalPartnerships
28 partnerships are on record, tiered gold sponsor, basis sponsor and kooperation.
- Gilead Oncology / Kitegold sponsorGold Sponsor of CARE & COACH Akademie. Gilead Sciences is a biopharmaceutical company focused on innovative medicines for areas with high medical need. Kite, a Gilead company, is a worldwide leader in CAR-T cell therapy. They sponsor the OncoCoach program and related courses including CAR-T cell therapy training.
- Lillygold sponsorGold Sponsor. Lilly develops transformative therapies connecting care with research to improve lives. They sponsor extended adjuvant therapy courses for breast cancer.
- MSD Sharp & Dohmegold sponsorGold Sponsor. MSD Sharp & Dohme focuses on oncology nursing care topics. They provide resources on communication with cancer patients and produce webinars on immunooncology indications.
- Stemline Therapeutics (Menarini Group)gold sponsorGold Sponsor. Part of the Menarini Group, focused on development and commercialization of novel oncology therapeutics. They sponsor biomarker-adapted therapy and antiemesis courses.
- AbbVie (Oncology)basis sponsorBasis Sponsor. AbbVie focuses on targeted therapies that counteract processes cancer cells need for survival. They are developing a dynamic pipeline of new therapies across more than 20 investigational drugs in over 300 clinical trials.
- Accord Healthcarebasis sponsorBasis Sponsor. One of Europe's leading companies for generics, biosimilars, and specialty pharmaceuticals. German subsidiary based in Munich with over 100 approved preparations. Ranked among top 3 in oncology and hematology generics in Germany.
- Amgenbasis sponsorBasis Sponsor. Biotechnology company using cutting-edge science to research biological mechanisms of diseases. Focus on KRAS G12C inhibitor Sotorasib for NSCLC treatment. Provides educational materials on lung cancer therapy.
- AOP Healthbasis sponsorBasis Sponsor. AOP Health Group includes AOP Orphan Pharmaceuticals GmbH headquartered in Vienna, Austria. Pioneer for integrated therapies for rare diseases and intensive care medicine for over 25 years. German subsidiary in Ismaning near Munich.
- Astellas Pharmabasis sponsorBasis Sponsor. Research-oriented pharmaceutical company committed to 'Changing Tomorrow' through innovative research. Focus areas: oncology, urology, ophthalmology, women's health, and transplantation. German office in Munich.
- BeOne Medicinesbasis sponsorBasis Sponsor. Building a broad, powerful pipeline and accelerating development through rigorous scientific methods to address the greatest unmet needs in cancer treatment worldwide.
- Biotest AGbasis sponsorBasis Sponsor. Provider of biological medicines derived from human plasma. Develops and produces at headquarters in Dreieich near Frankfurt. Products used in clinical immunology, hematology, and intensive care medicine.
- Bristol Myers Squibbbasis sponsorBasis Sponsor. Service portal for nursing and specialist staff in hematology and oncology. Provides podcast 'Pflege für die Ohren' (Nursing for the Ears) with 10-minute episodes and practical tips. German contact portal at pflege-onkologie.de.
- CSL Behringbasis sponsorBasis Sponsor. Global biotechnology company with promise to save lives and improve quality of life. Offers broad range of plasma-derived and recombinant therapies. Founded over 100 years ago. Information portal infekte-bei-krebs.de for cancer patients.
- Eisaibasis sponsorBasis Sponsor. Focus on patients and relatives, and improving healthcare. They sponsor courses on effective side effects management.
- Esteve Pharmaceuticalsbasis sponsorBasis Sponsor. International pharmaceutical company founded in 1929, headquartered in Barcelona. German office in Berlin. Specializes in highly specialized therapies in oncology, endocrinology, and anti-infectives.
- GlaxoSmithKline (GSK)basis sponsorBasis Sponsor. Global research-based pharmaceutical company with three business units: pharmaceuticals, vaccines, and consumer healthcare. Committed to providing differentiated, high-quality health products to people who need them.
- Grifolsbasis sponsorBasis Sponsor. Global healthcare company founded in Barcelona in 1909, improving health and well-being in over 110 countries. Pioneer in plasma industry with world's largest network of donation centers with over 390 locations. Focus on immunology, hepatology, pulmonology, hematology, neurology, and infectious diseases.
- Ipsenbasis sponsorBasis Sponsor. DACH regional headquarters (Germany, Austria, Switzerland) for over 41 years. Focus on oncology, neurosciences, and rare diseases. Committed to optimizing diagnostic and therapy pathways for patients.
- Johnson & Johnsonbasis sponsorBasis Sponsor. Leading research-based pharmaceutical company. #2 in German pharmaceutical market. Over 46,000 employees worldwide, about 1,000 in Germany. Invested approximately €30.3 million daily in R&D in 2023. Focus areas: oncology, immunology, neurosciences, PAH, and ophthalmology.
- Novartisbasis sponsorBasis Sponsor. Focus on innovative medicines improving and extending lives. Products reach over 250 million people worldwide. Approximately 2,600 employees (FTE) in Germany at six locations. 'German champion' in clinical research. Therapeutic areas: cardiovascular, immunology, neurology, solid tumors, hematology.
- Novocurebasis sponsorBasis Sponsor. Global oncology company focused on extending survival in aggressive forms of cancer. Developer of Tumor Treating Fields (TTFields) therapy. Over 35,000 patients treated worldwide. Products: Optune Gio for glioma, Optune Lua for mesothelioma and metastatic NSCLC.
- Otsuka Pharmabasis sponsorBasis Sponsor. Global healthcare company with philosophy 'Otsuka-people creating new products for better health worldwide.' Focus on drugs for areas of high medical need and dietary supplements. Otsuka Europe has approximately 500 employees. Focus: oncology, nephrology, rare diseases, psychiatric/neurological diseases, digital medicine.
- Pierre Fabrebasis sponsorBasis Sponsor. Pharmaceutical company founded by a pharmacist from Tarn region, converted to state-recognized nonprofit foundation. 86% majority shareholder of Pierre Fabre Group. Foundation mission: enabling access to healthcare and basic medicines for populations in emerging countries. Focus on oncology training including BRAF-mutated tumors.
- Seagenbasis sponsorBasis Sponsor. Global biotech company dedicated to improving cancer care. Pioneer in Antibody-Drug Conjugates (ADCs) for over 20 years. Developing transformative therapies for solid and hematological tumors.
- Servierbasis sponsorBasis Sponsor. Global research-oriented pharmaceutical company managed as a private foundation since 1954. Committed to patient health and well-being, social contribution, and environmental sustainability. Sponsors ivosidenib therapy management courses.
- Viatrisbasis sponsorBasis Sponsor. Vision: healthcare as it should be. Broad portfolio of over 400 products in Germany including complex medicines, biosimilars (immunology, oncology, diabetology), antithrombotics, and influenza vaccines. Sponsors cytopharmacy and burnout prophylaxis courses.
- Daiichi Sankyo / AstraZenecakooperationCooperation partner. The collaboration combines scientific and technological excellence of Daiichi Sankyo with global experience and resources of AstraZeneca in oncology. Listed under 'Kooperationen' (cooperations) section.
- Medical Networks (North, Rhine-Main area)kooperationMedical networks including 'Neues medizinisches Netzwerk im Norden' and 'Medizinisches Netzwerk für das Rhein-Main-Gebiet'. Healthcare communication on demand partnerships.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
CARE & COACH Akademie competitors and assessment
Company assessmentDirect peers
- Springer Pflege: Leading German-language continuing education platform for nurses offering Springer-certified CNE points and online courses. Directly comparable: similar DACH nursing CE focus, accreditation integration, and pharmaceutical sponsor-funded content.
- Thieme CNE (Georg Thieme Verlag): Thieme's CNE program provides certified nursing continuing education across German hospitals with online modules and pharmaceutical sponsorship. Comparable model: accredited nursing CE, multi-format modules, pharma-funded content.
- medupdate: German CME/CNE platform offering accredited online seminars and webinars for physicians and nurses across specialties including oncology. Comparable: pharma-sponsored live and on-demand accredited CE for healthcare professionals.
- Healthcare-Akademie: German continuing education provider for healthcare professionals offering accredited nursing and medical courses. Comparable in target audience (German healthcare professionals), accreditation framework, and online course delivery.
Broad incumbents
- Oncology Nursing Society (ONS): US-based professional society offering oncology nursing certification, CE, and learning resources. Comparable in domain (oncology nursing education) and accreditation value, but broader scope and US-centric.
- Relias (formerly CE Direct): Large US healthcare CE and training platform serving nurses across specialties with accredited courses. Comparable in nursing CE delivery model, though broader than oncology and not German-market focused.
Regional players
- Forum Gesundheitsmedizin: German provider of accredited healthcare professional training with pharmaceutical-sponsored content. Comparable in pharma-funded nursing/HCP CE delivery within Germany, though broader specialty coverage.
Emerging players
- AMBOSS Pflege: AMBOSS is expanding from physician decision-support into nursing CE/learning content in Germany. Comparable audience (German healthcare professionals) and emerging CE offerings, though nursing vertical is still newer than CARE & COACH's oncology depth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks4 records
Key highlights5 records
Customer concentration
CARE & COACH Akademie social profiles
Digital presenceCARE & COACH Akademie financial estimates
Financial estimateRevenue estimate
Valuation estimate
CARE & COACH Akademie leadership team
Management profileNumber of profiles
Profiles7 records
CARE & COACH Akademie funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CARE & COACH Akademie M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CARE & COACH Akademie
What does CARE & COACH Akademie do?
CARE & COACH Akademie operates a digital continuing education platform for oncology nursing professionals in German-speaking regions, delivering hybrid training that combines in-person workshops, live webinars, and asynchronous e-learning modules. The flagship OncoCoach six-month certification program covers diagnostics, oncology therapies, patient coaching, and communication skills, while individual modules (e.g., CAR-T cell therapy, biomarker-adapted therapy, antiemetics) are sold at €50–70 each alongside free webinars and short-form video clips.
Is CARE & COACH Akademie a public or private company?
CARE & COACH Akademie is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CARE & COACH Akademie founded?
CARE & COACH Akademie was founded in 2022.
Where is CARE & COACH Akademie based?
CARE & COACH Akademie is headquartered in Köln, Germany, in the Europe region.
How does CARE & COACH Akademie make money?
Three revenue lines are on record. Course and Module Fees are the primary driver. The others are free Educational Content and pharmaceutical Sponsorships.
Who are CARE & COACH Akademie's main competitors?
Direct peers on record are Springer Pflege, Thieme CNE (Georg Thieme Verlag), medupdate and Healthcare-Akademie. Broad incumbents are Oncology Nursing Society (ONS) and Relias (formerly CE Direct). Forum Gesundheitsmedizin is listed as a regional player. AMBOSS Pflege is listed as an emerging player.
Does CARE & COACH Akademie have an API?
No public API is recorded for CARE & COACH Akademie.
What industry is CARE & COACH Akademie in?
CARE & COACH Akademie's product category is Continuing Medical Education. Its primary akta.pro industry code is EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE), with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 611430 and its SIC code is 8200.